bexarotene has been researched along with Centriacinar Emphysema in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, U; Kakuta, H; Kanehiro, A; Kataoka, M; Kiura, K; Maeda, Y; Miyahara, N; Morichika, D; Oda, N; Senoo, S; Taniguchi, A; Tanimoto, M | 1 |
1 other study(ies) available for bexarotene and Centriacinar Emphysema
| Article | Year |
|---|---|
A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
Topics: Animals; Bexarotene; Cigarette Smoking; Female; Inflammation; Mice; Mice, Inbred BALB C; Pulmonary Emphysema; Retinoid X Receptors | 2019 |